Systemic immune cell dynamics during coronavirus disease 2019 (COVID-19) are extensively
documented, but these are less well studied in the (upper) respiratory tract, where severe …

Since multiple different T-cell receptor (TCR) sequences can bind to the same peptide-MHC
combination and the number of TCR-sequences that can theoretically be generated even …

Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels …

In the context of HLA-DP-mismatched allogeneic stem cell transplantation, mismatched HLA-DP
alleles can provoke profound allo-HLA-DP-specific immune responses from the donor T-…

Adoptive cellular therapies with T cells are increasingly used to treat a variety of conditions.
For instance, in a recent phase 1/2 trial, we prophylactically administered multivirus-specific T…

Fractional dosing can be a cost-effective vaccination strategy to accelerate individual and
herd immunity in a pandemic. We assessed the immunogenicity and safety of primary …

Background Adoptive transfer of genetically engineered T cells expressing antigen-specific
T-cell receptors (TCRs) is an appealing therapeutic approach for Epstein-Barr virus (EBV)–…

Bacterial capsular polysaccharides are important vaccine immunogens. However, the study
of polysaccharide-specific immune responses has been hindered by technical restrictions. …

T-cell products derived from third-party donors are clinically applied, but harbor the risk of off-target
toxicity via induction of allo-HLA cross-reactivity directed against mismatched alleles. …

Alemtuzumab (ALM) is used for T cell depletion in the context of allogeneic hematopoietic
stem cell transplantation (alloSCT) to prevent acute graft-versus-host disease and graft …